RICT 2017 will greatly contribute to a higher visibility of the Region towards the new challenges and thus, help to structure and strengthen the Research, Innovation and Development in the domain of “Drug Discovery & Selection”.
During the meeting the P. Ehrlich Lecture Prize of the ‘Société de Chimie Thérapeutique’ will be awarded to a researcher or a research team for his or her outstanding contributions to medicinal chemistry. Furthermore, the Pierre Fabre Award for Therapeutic Innovation will be attributed to a researcher having accomplished a decisive action or made a discovery contributing to a therapeutic innovation. In addition, a poster session will provide the opportunity for all participants to present their current results. “Best poster” prizes will be attributed at the end of the meeting.
Attending the 2 day event is our Head of Medicinal Chemistry, Dr Paul Bradley. For more information visit the LD Organisation website.